Concepedia

Concept

childhood arthritis

Parents

3.2K

Publications

143.6K

Citations

12.9K

Authors

2.9K

Institutions

Phenotype-Driven Pediatric Arthritis

1977 - 1983

The period sketched a paradigm shift toward phenotype-driven pediatric arthritis, expanding the disease spectrum beyond juvenile rheumatoid arthritis to include psoriatic-like arthritides and related pediatric conditions. Immunogenetic distinctions between juvenile and adult arthritis emerged as a central organizing framework, with HLA associations shaping classification and prognosis. Imaging advances and documented responses to long-acting therapies linked structural outcomes to disease activity, while the field’s historical and conceptual development solidified pediatric rheumatology as a distinct discipline.

Expansion of pediatric rheumatology phenotypes and a shift toward phenotype-based classification, from Juvenile RA series to psoriatic arthritis and related conditions, plus historical framing of the field [2][10][14][6][19][16][4][18].

Immunogenetics delineate juvenile versus adult arthritis and related syndromes, with distinct HLA-D associations in juvenile RA and HLA-B27 signals in Reiter's syndrome (childhood), indicating genetic predisposition shaping disease expression [3][19][12].

Systemic autoimmune diseases in childhood show distinct prognostic trajectories (SLE, collagen diseases, familial lupus) requiring pediatric-specific management and outcome expectations [9][5][17].

Imaging and structural consequences intertwine with treatment responses in pediatric arthritis, evidenced by bone density alterations and radiologic response patterns to long-acting therapies [11][8].

Historical and conceptual development of pediatric rheumatology, including Still's accounts and later reassessment, frames the field's evolution and shaping of pediatric arthritis knowledge [16][13].

Biopsychosocial Pediatric PRO Paradigm

1984 - 1997

Juvenile Idiopathic Arthritis Outcomes

1998 - 2004

Targeted Biologics in JIA

2005 - 2011

Remission-Driven Biologic Therapy

2012 - 2016

Biomarker-Driven Care Standardization

2017 - 2023